Background: The authors frequently employed selective peripheral neurotomy (SPN) as the primary treatment of severe intractable focal and multifocal spastic hypertonia. We occasionally operated SPN in diffuse spastic disorders. Objective: To study surgical outcome of SPN in terms of severity of spasticity and functional condition. Methods: Patients harboring refractory harmful spasticity of various origins were enrolled into the present study. They were clinically evaluated by using the Modified Ashworth Scale (MAS), passive range of motion (PROM) and functional status. These variables were compared between pre- and postsurgery by using the paired t test and the Wilcoxon signed-rank matched-pairs test. Results: One hundred and forty-one SPNs were accomplished in 33 patients. Overall mean pre- and postoperative MAS and PROM were 3.0 and 0.7 (p < 0.001) and 78.3 and 102.3° (p < 0.001), respectively. Analysis of individual SPN subgroups also demonstrated statistically significant improvement of both parameters. Furthermore, we found significant gait improvement among 10 ambulatory subjects. Nine bed-bound cases attained significant enhancement of sitting competency and ambulatory condition. Conclusion: SPN is an efficacious neurosurgical intervention in the treatment of spasticity. It is apparently beneficial in the reduction of spasticity, amelioration of functional status, facilitation of patient care and prevention of long-term musculoskeletal sequelae.

Keywords:
Spasticity, Peripheral denervation, Selective peripheral neurotomy, Modified Ashworth Scale, Range of motion
1.
Sheean G: The pathophysiology of spasticity. Eur J Neurol 2002;9:3-9.
2.
Tabtimsuwan S, Sitthinamsuwan B, Chankaew E: Spasticity: a comprehensive review. Siriraj Med J 2011;63:32-37.
3.
Steinbok P: Selection of treatment modalities in children with spastic cerebral palsy. Neurosurg Focus 2006;21:E4.
4.
Abbruzzese G: The medical management of spasticity. Eur J Neurol 2002;9:30-34.
5.
Ward AB: A summary of spasticity management - a treatment algorithm. Eur J Neurol 2002;9:48-52.
6.
Sitthinamsuwan B, Nunta-aree S, Kumthornthip W: Neurosurgical management for cerebral palsy. II. Neuromodulation and multidisciplinary management. J Thai Rehab Med 2012;22:1-9.
7.
Sitthinamsuwan B, Nunta-aree S: Functional peripheral nerve surgery. Siriraj Med J 2010;62:106-111.
8.
Sitthinamsuwan B, Nunta-Aree S, Nitising A, Tabtimsuwan S: The neurosurgical treatment of spasticity - an overview. Neurol Surg 2010;1:44-60.
9.
Sitthinamsuwan B, Phonwijit L, Ploypetch T: Neurosurgical management for cerebral palsy. I. Neuroablation. J Thai Rehab Med 2011;21:73-84.
10.
Bohannon RW, Smith MB: Inter-rater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206-207.
11.
Johnson GR: Outcome measures of spasticity. Eur J Neurol 2002;9:10-16.
12.
Elovic EP, Simone LK, Zafonte R: Outcome assessment for spasticity management in the patient with traumatic brain injury: the state of the art. J Head Trauma Rehabil 2004;19:155-177.
13.
Sindou M, Mertens P: Neurosurgery for spasticity. Stereotact Funct Neurosurg 2002;74:217-221.
14.
Mandigo CE, Anderson RC: Management of childhood spasticity: a neurosurgical perspective. Pediatr Ann 2006;35:354-362.
15.
Sindou MP, Simon F, Mertens P, Decq P: Selective peripheral neurotomy (SPN) for spasticity in childhood. Childs Nerv Syst 2007;23:957-970.
16.
Sindou MP, Mertens P: Decision-making for neurosurgical treatment of disabling spasticity in adults. Oper Tech Neurosurg 2005;7:113-119.
17.
Bleyenheuft C, Detrembleur C, Deltombe T, Fomekong E, Lejeune TM: Quantitative assessment of anaesthetic nerve block and neurotomy in spastic equinus foot: a review of two cases. J Rehabil Med 2008;40:879-881.
18.
Sitthinamsuwan B, Chanvanitkulchai K, Nunta-aree S, Kumthornthip W, Pisarnpong A, Ploypetch T: Combined ablative neurosurgical procedures in a patient with mixed spastic and dystonic cerebral palsy. Stereotact Funct Neurosurg 2010;88:187-192.
19.
Sindou M, Mertens P, Jeanmonod D: Microsurgical ablative procedures in the peripheral nerves and dorsal root entry zone for relief of focal spasticity in the limbs. Stereotact Funct Neurosurg 1990;54-55:140-146.
20.
Msaddi AK, Mazroue AR, Shahwan S, al Amri N, Dubayan N, Livingston D, Moutaery KR: Microsurgical selective peripheral neurotomy in the treatment of spasticity in cerebral-palsy children. Stereotact Funct Neurosurg 1997;69:251-258.
21.
Decq P, Filipetti P, Feve A, Djindjian M, Saraoui A, Kéravel Y: Peripheral selective neurotomy of the brachial plexus collateral branches for treatment of the spastic shoulder: anatomical study and clinical results in five patients. J Neurosurg 1997;86:648-653.
22.
Purohit AK, Raju BS, Kumar KS, Mallikarjun KD: Selective musculocutaneous fasciculotomy for spastic elbow in cerebral palsy: a preliminary study. Acta Neurochir (Wien) 1998;140:473-478.
23.
Maarrawi J, Mertens P, Luaute J, Vial C, Chardonnet N, Cosson M, Sindou M: Long-term functional results of selective peripheral neurotomy for the treatment of spastic upper limb: prospective study in 31 patients. J Neurosurg 2006;104:215-225.
24.
Buffenoir K, Rigoard P, Ferrand-Sorbets S, Lapierre F: Retrospective study of the long-term results of selective peripheral neurotomy for the treatment of spastic upper limb. Neurochirurgie 2009;55:S150-S160.
25.
Fouad W: Management of spastic hand by selective peripheral neurotomies. Alexandria J Med 2011;47:201-208.
26.
Puligopu AK, Purohit AK: Outcome of selective motor fasciculotomy in the treatment of upper limb spasticity. J Pediatr Neurosci 2011;6:S118-S125.
27.
Sindou M, Mertens P: Selective neurotomy of the tibial nerve for treatment of the spastic foot. Neurosurgery 1988;23:738-744.
28.
Abdennebi B, Bougatene B: Selective neurotomies for relief of spasticity focalized to the foot and to the knee flexors. Results in a series of 58 patients. Acta Neurochir (Wien) 1996;138:917-920.
29.
Decq P, Filipetti P, Cubillos A, Slavov V, Lefaucheur JP, Nguyen JP: Soleus neurotomy for treatment of the spastic equinus foot. Groupe d'Evaluation et de Traitement de la Spasticité et de la Dystonie. Neurosurgery 2000;47:1154-1160.
30.
Deltombe T, Gustin T, Laloux P, De Cloedt P, De Wispelaere JF, Hanson P: Selective fasicular neurotomy for spastic equinovarus foot deformity in cerebral palsy children. Acta Orthop Belg 2001;67:1-5.
31.
Buffenoir K, Roujeau T, Lapierre F, Menei P, Menegalli-Boggelli D, Mertens P, Decq P: Spastic equinus foot: multicenter study of the long-term results of tibial neurotomy. Neurosurgery 2004;55:1130-1137.
32.
Rousseaux M, Buisset N, Daveluy W, Kozlowski O, Blond S: Long-term effect of tibial nerve neurotomy in stroke patients with lower limb spasticity. J Neurol Sci 2009;278:71-76.
33.
Deltombe T, Gustin T: Selective tibial neurotomy in the treatment of spastic equinovarus foot in hemiplegic patients: a 2-year longitudinal follow-up of 30 cases. Arch Phys Med Rehabil 2010;91:1025-1030.
34.
Bollens B, Deltombe T, Detrembleur C, Gustin T, Stoquart G, Lejeune TM: Effects of selective tibial nerve neurotomy as a treatment for adults presenting with spastic equinovarus foot: a systematic review. J Rehabil Med 2011;43:277-282.
35.
Rousseaux M, Buisset N, Daveluy W, Kozlowski O, Blond S: Comparison of botulinum toxin injection and neurotomy in patients with distal lower limb spasticity. Eur J Neurol 2008;15:506-511.
36.
Sitthinamsuwan B, Parnnang C, Nunta-Aree S, Chankaew E, Papatthanaporn A: An innovation of intraoperative electrical nerve stimulator. Neurol Surg 2010;1:65-82.
37.
Wangjam KB, Joy Singh AK, Romi Singh N, Nilachandra L, Bimol N: EMG guided selective tibial neurectomy in reduction of gastro-soleus spasticity - its role in the treatment of cerebral palsy. Indian J Phys Med Rehabil 2001;12:1-5.
38.
Sitthinamsuwan B, Chanvanitkulchai K, Phonwijit L, Nunta-aree S, Kumthornthip W, Ploypetch T: Improvement of sitting ability and ambulation status after selective peripheral neurotomy of the sciatic hamstring nerve together with obturator branches for severe spasticity of the lower extremities. Stereotact Funct Neurosurg 2012;90:335-343.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.